We are live on ! Find out more
RGEN icon

Repligen

Positive
Neutral
Negative
Sentiment 3-Months
Positive 22.2%
Neutral 55.6%
Negative 22.2%

Neutral
GlobeNewsWire
3 days ago
Repligen to Report Second Quarter 2026 Financial Results
Webcast and Conference Call to Be Held Tuesday, July 28, 2026, at 8:00 a.m. ET Webcast and Conference Call to Be Held Tuesday, July 28, 2026, at 8:00 a.m. ET
Repligen to Report Second Quarter 2026 Financial Results
Negative
Zacks Investment Research
1 month ago
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?
Neutral
Seeking Alpha
1 month ago
Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update
During the first quarter of 2026, the largest portfolio sector weightings were Health Care and Industrials. RBC Bearings Incorporated, Cognex Corporation and Nebius Group were among the top contributors to performance. Repligen Corporation, Agilysys, Inc., and GeneDx Holdings Corp. were among the top detractors from performance.
Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update
Neutral
Seeking Alpha
1 month ago
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Positive
Seeking Alpha
1 month ago
Repligen Has A Cleaner Recovery Angle, But With High Valuation
Repligen is recovering after a difficult 2024, with Q1 2026 revenue up 15% and 11% organic. Polymem, China, PAT, and the Transformation Office make the story cleaner, but execution still matters.
Repligen Has A Cleaner Recovery Angle, But With High Valuation
Neutral
GlobeNewsWire
1 month ago
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair 46th Annual Growth Stock Conference in Chicago, IL. Olivier Loeillot, President and Chief Executive Officer, will present a company overview on June 3rd at 10:40 a.m. CT.
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
Neutral
GlobeNewsWire
1 month ago
Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate Sustainability Report and related reporting framework disclosures. Themed “Driving Sustainable Growth Together”, this report communicates the company's progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities, and Pathways to Success. Also included in the 2025 Sustainability Report are detailed disclosures aligned with the United Nations Sustainable Development Goals (UN SDGs) and three key reporting frameworks: the Global Reporting Initiative (GRI) Standards, Sustainability Accounting Standards Board (SASB) Standards and the Task Force on Climate-related Financial Disclosures (TCFD), now part of the IFRS Sustainability Alliance.
Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report
Neutral
Seeking Alpha
2 months ago
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral
GlobeNewsWire
2 months ago
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Bank of America Securities 2026 Global Healthcare Conference, being held May 12-14 in Las Vegas, Nevada.
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
Positive
Zacks Investment Research
2 months ago
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its 2026 EPS view.
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises